Transkripte Magenta Therapeutics

Aktien

Markt geschlossen - Nasdaq 22:00:00 25.09.2026			Perf. 5 T	Veränd. 1. Jan.
88,55 ^USD	-2,38 %		-10,29 %	+691,08 %

11.09.23	Dianthus Therapeutics, Inc. hat die Übernahme von Magenta Therapeutics, Inc. (NasdaqGM:MGTA) von einer Gruppe von Aktionären in einer Reverse-Merger-Transaktion abgeschlossen.	CI
03.08.23	Magenta Therapeutics, Inc. meldet Ergebnis für das zweite Quartal und die sechs Monate bis zum 30. Juni 2023	CI

03.05.23	Dianthus Therapeutics, Inc., Magenta Therapeutics, Inc. - M&A Call
13.12.22	Magenta Therapeutics, Inc. - Special Call
08.11.22	Magenta Therapeutics, Inc. Presents at Credit Suisse 31st Annual Healthcare Conference, Nov-08-2022 08:00 AM
13.01.22	Magenta Therapeutics, Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-13-2022 09:45 AM
10.06.21	Magenta Therapeutics, Inc. Presents at Goldman Sachs 42nd Annual Global Healthcare Conference, Jun-10-2021 04:40 PM
12.05.21	Magenta Therapeutics, Inc. - Special Call
14.01.21	Magenta Therapeutics, Inc. Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-14-2021 07:50 AM
11.06.20	Magenta Therapeutics, Inc. Presents at Goldman Sachs 41st Annual Global Healthcare Conference, Jun-11-2020 05:50 AM
07.05.20	Magenta Therapeutics, Inc. - Special Call
15.01.20	Magenta Therapeutics, Inc. Presents at 38th Annual J.P Morgan Healthcare Conference, Jan-13-2020 through Jan-16-2020
08.12.19	Magenta Therapeutics, Inc. - Shareholder/Analyst Call
11.06.19	Magenta Therapeutics, Inc. Presents at 40th Annual Goldman Sachs Global Healthcare Conference, Jun-11-2019 02:40 PM
09.01.19	Magenta Therapeutics, Inc. Presents at JP Morgan 37th Annual Healthcare conference, Jan-09-2019 09:30 AM